[Infections due to mycobacteria and anti-TNFalpha drugs].
Regnier
S
S
Caumes
E
E
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D006801:Humans; D000069285:Infliximab; D009164:Mycobacterium Infections / Q000188:drug therapy*; D012216:Rheumatic Diseases / Q000139:chemically induced / Q000188:drug therapy; D012449:Safety; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab